NDC 67618-0120-12 — Senokot standardized senna concentrate 17.2 mg

🆔 Identity & classification

FDA NDC (as labeled) 67618-120-12

Product NDC 67618-120

11-digit billing NDC 67618012012

NCPDP billing unit EA — each (per item)

RxCUI 602802, 1039965

UNII 3FYP5M0IJX

UPC 0367618120125, 0367618120064

Application # M007

SPL Set ID d5bf67e5-82c6-edbf-e9ec-e027fdd47c84

DEA schedule Non-controlled

Marketing category OTC MONOGRAPH DRUG

Marketing status On market

FDA listing status Listed (active directory)

Marketing start 1988-09-01

Route ORAL

Dosage form TABLET, FILM COATED

Substance SENNOSIDES

GPI-14 46200060200318

GPI class Senokot Extra Strength

GCN Seq No 060282

GCN 26397

HICL code 001289

Ingredient (HICL) Sennosides

HIC1 code D

Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System

HIC2 code D6

Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon

HIC3 code D6S

Therapeutic class — specific (HIC3) Laxatives And Cathartics

AHFS code 56:12.00.00

AHFS class Cathartics And Laxatives

FDB label name SENOKOT EXTRA STR 17.2 MG TAB

FDB brand name Senokot

Legend status O — Over-the-counter (OTC) drug or device

Why two NDCs? The FDA registers this code as 67618-120-12 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 67618-0120-12. Same drug, same package — only the format differs.

Where does this data come from?

Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives

Where does this data come from?

Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerAtlantis Consumer Healthcare, Inc.

FDA applicationM007 (OTC MONOGRAPH DRUG)

Labeler code67618

First marketedSep 1988

Product typeHuman Otc Drug

Portfolio17 products on file

🔎 All NDCs from Atlantis Consumer Healthcare, Inc.

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).

Where does this data come from?

Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name SENOKOT EXTRA STR 17.2 MG TAB Ingredient Sennosides

📖 What it is MedlinePlus · NLM

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗

📗 Our plain-language guide HelloPharmacist

Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
How long does it take for senna to work?
Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...

📖 Read our full Senna guide →

Patient education

📘 MedlinePlus patient leaflet ↗

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →

Where does this data come from?

Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color Brown

ShapeRound

ImprintX

Size9 mm

ScoringNot scored

One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.

Where does this data come from?

Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

UNII M28OL1HH48
Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
UNII O7TSZ97GEP
A mineral compound that serves as a filler and binding agent in tablets and capsules. It adds bulk to the medicine and helps hold ingredients together during manufacturing.
UNII 3NXW29V3WO
Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
UNII J2B2A4N98G
Lactose is a natural sugar derived from milk. In medications, it serves as a filler and binder to add bulk and help hold tablet or capsule ingredients together during manufacturing.
UNII N6K5787QVP
Light mineral oil is a clear, odorless liquid derived from petroleum. In medicines, it acts as a lubricant and emollient to help the product spread smoothly and improve texture.
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
UNII 4ELV7Z65AP
Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
UNII 7SEV7J4R1U
A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
UNII W4888I119H
Tartaric acid is a natural organic acid found in grapes and tamarinds. In medicines, it works as a buffer to control acidity, an antioxidant to prevent spoilage, and sometimes a flavoring or binding agent.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescroscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?

Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?

No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.

Why might an inactive ingredient be missing?

Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.

Can inactive ingredients matter?

Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price system	Per ea	Per package
Retail pharmacies payNADAC · weekly	$0.416	$5.00 / 12 tablets
Medicaid paysCMS SDUD · 12 mo	$0.5428	$6.51 / 12 tablets
Medicare drug plans payPart D · quarterly	No Part D plan price is available for this NDC in our data.

NADAC price history (per ea) — tap or hover for the price & month

▲ Up 8% over the last 6 months.

Where does this data come from?

NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

Product	Labeler	Pack	NADAC/unit	TE	Status	Price vs. this
Senokot 17.2 mgthis 67618-0120-12	Atlantis	12 tablets	$0.416	—	Availability likely	—

About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.

Where does this data come from?

Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️

1988

On the market since

Sep 1988

📍

2026

Currently FDA-listed

38 years listed

🔒

·

No generic listed yet

brand only

ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?

Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 67618-0120-12, not the drug overall. Other pack sizes report separately.

💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.

📅 Q1 2025 – Q1 2026 · 5 quarters of data

ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.

Prescriptions last 4 qtrs

1.7K

Units reimbursed last 4 qtrs

60.1K

Gross reimbursed last 4 qtrs

$32.6K

Avg / prescription

$19.25

Avg / unit

$0.5428

Latest quarter Q1 2026

407Rx

Medicaid pays / ea

$0.5428

gross reimbursed

vs

NADAC / ea

$0.4163

acquisition cost

=

Spread

+$0.1265

+30% vs cost

What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.

Fee-for-service vs managed care ⓘ

13% FFS 87% MCO

Fee-for-service · 225 Rx Managed care · 1,469 Rx

State Medicaid map

Units reimbursed · per 100k residents

4.8339

gray = no data reported ⓘ

Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.

Tap or hover a state

…for its Medicaid breakdown

🏆 Top states by units · per 100k residents

1 Ohio 339 /100k

2 Michigan 145 /100k

3 New Jersey 26.9 /100k

4 Virginia 10.7 /100k

5 Maryland 5.7 /100k

6 California 4.8 /100k

National units — by quarter

💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.

12 tablets this page67618-0120-12 1,694 Rx · $32,615

36 tablets67618-0120-06 No Medicaid data

36 tablets67618-0120-72 No Medicaid data

72 tablets67618-0120-73 No Medicaid data

Drug total (last 4 qtrs): 1,694 Rx · 60,082 units · $32,615 gross reimbursed

Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Senokot (this brand).

Top reported reactions

Fatigue1,755

Constipation1,339

Pain1,311

Headache1,150

Nausea1,140

Diarrhoea1,005

Dyspnoea954

Age at onset

Child14

Adolescent15

Adult880

Elderly883

Reporter sex

Male · 41%

Female · 59%

Unknown · 0%

Serious outcomes

Death2,116

Life-threatening611

Disabling342

Reports over time (by year) — tap or hover for the count & year

Most recent year is provisional (FAERS lags ~3 months).

Where does this data come from?

Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDC	Description	Per unit	Per pack	Marketing start	Status
67618-0120-06	36 TABLET, FILM COATED in 1 BOTTLE (67618-120-06)	—	—	1988-09-01	Active
67618-0120-12 You're viewing this	1 BLISTER PACK in 1 CARTON (67618-120-12) / 12 TABLET, FILM COATED in 1 BLISTER PACK	$0.4163 / ea	$5.00	1988-09-01	Active
67618-0120-72	2 CARTON in 1 PACKAGE (67618-120-72) / 1 BOTTLE in 1 CARTON / 36 TABLET, FILM COATED in 1 BOTTLE	—	—	2024-01-01	Active
67618-0120-73	72 TABLET, FILM COATED in 1 BOTTLE (67618-120-73)	—	—	2025-11-15	Active

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in NDC 67618-0120-12?

NDC 67618-0120-12 is a 12-count package — 1 blister pack in 1 carton / 12 tablet, film coated in 1 blister pack.

What is the difference between NDC 67618-0120-12 and NDC 67618-0120-06?

Both are Senokot standardized senna concentrate 17.2 mg Tablet, Film Coated — the drug itself is identical. NDC 67618-0120-12 is the 12-count package, while NDC 67618-0120-06 is the 36 tablets package.

What NDC number is used to bill for this package of Senokot standardized senna concentrate 17.2 mg Tablet, Film Coated?

Bill NDC 67618-0120-12 — the 11-digit billing format is 67618012012. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.

🎯 Indications and Usage ⏱️ Dosage and Administration 💊 Dosage Forms and Strengths ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose

🎯 Indications and Usage 12 words ▾

Uses relieves occasional constipation (irregularity) generally causes bowel movement in 6-12 hours

⏱️ Dosage and Administration 11 words ▾

Directions take preferably at bedtime or as directed by a doctor

💊 Dosage Forms and Strengths 48 words ▾

Dosage Forms & Strengths age startingdosage maximumdosage adults and children 12 yearsof age and over 1 tablet once a day 2 tablets twice aday children 6 to under 12 years ½ tablet once a day 1 tablet twice aday children under 6 ask a doctor ask a doctor

⚠️ Warnings 16 words ▾

Warnings Do not use laxative products for longer than 1 week unless directed by a doctor

🧪 Active Ingredient 8 words ▾

Active ingredient (in each tablet) Sennosides 17.2 mg

🧪 Inactive Ingredients 19 words ▾

Inactive Ingredients croscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid

🎯 Purpose 2 words ▾

Purpose Laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

🔗 Related NDC lookups

🧪 All Standardized Senna Concentrate NDCsSame ingredient 🏭 All Atlantis labeler NDCsLabeler code 67618 📖 Read the Standardized Senna Concentrate drug informationUses, warnings & side effects

💊 Related drugs in this class

Other drugs that share this product’s specific therapeutic class — Laxatives And Cathartics.

Castor Oil 00363-0078-26 Bisacodyl 00363-0327-03

Where does this data come from?

Other drugs sharing this product’s First Databank therapeutic class (HIC3). Each links to that NDC’s page in our directory.

Senokot standardized senna concentrate 17.2 mg Tablet, Film Coated, 12-count

🆔 Identity & classification

🏷️ RxNorm drug class

🏭 Manufacturer & labeler

🩺 Clinical

Patient education

Supplement & herbal interactions

💊 What it looks like

🧪 Inactive Ingredients / Excipients

Inactive ingredient FAQ

💲 Pricing

🔁 Therapeutic equivalents

⏳ Availability & generic status

🗺️ Medicaid utilization & spend

💊 Medicaid utilization by pack size

🔬 Reported adverse events (FAERS)

Top reported reactions

Age at onset

Reporter sex

Serious outcomes

📦 Packaging — all sizes for this product

Pack size FAQ

📄 FDA label — Drug Facts FDA SPL

🔗 Related NDC lookups

💊 Related drugs in this class